Skip to main content
GNTA logo

Genenta Science S.p.A. (GNTA) Stock Analysis

DELISTED

What happened to Genenta Science S.p.A. (GNTA) stock?

Genenta Science S.p.A. (GNTA) no longer trades on public markets. The figures below are historical and are not a current quote.

Status:
Delisted — no longer trades
MCap: $18.0M| Vol: 249.3K| Target: $6.89 (Record date unavailable) (estimate, not advice)|

Market cap $18.0M is the value of all shares combined.

Data from FMP · Methodology

For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR

Genenta Science S.p.A. (GNTA). Genenta Science S.p.A. is an Italian clinical-stage biotechnology company focused on developing hematopoietic stem cell gene therapies for solid tumors. Its lead product candidate, Temferon, is currently undergoing Phase 1/2a clinical evaluation for glioblastoma multiforme.

Last analyzed: Jun 14, 2026
Genenta Science S.p.A. is an Italian clinical-stage biotechnology company focused on developing hematopoietic stem cell gene therapies for solid tumors. Its lead product candidate, Temferon, is currently undergoing Phase 1/2a clinical evaluation for glioblastoma multiforme.

Genenta Science S.p.A. (GNTA) Industrial Operations Profile

Employees9
Model self-rating on this text: 66% (not a measure of the evidence) Updated: Jun 14, 2026

Genenta Science S.p.A. ADR Information Sponsored

Genenta Science S.p.A. (GNTA) trades in the U.S. as an American Depositary Receipt (ADR).

  • ADR Level: 2
  • ADR Ratio: 1:1

More about this archive record

Can I still buy GNTA shares?

No. GNTA stopped trading on public markets, so the shares are not available through a broker. Anything you see quoted for GNTA elsewhere is historical data, not a live market.

Are the figures on this page current?

No. Every number here is the last value recorded before GNTA stopped trading. Nothing on this page updates, and none of it is a current quote.

Why does this page still exist?

Because people still search for what happened to Genenta Science S.p.A.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Analysis updated
Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. Last updated: .

Data provided for informational purposes only.